4.5 Article

A novel human CD4(+) T-cell inducer subset with potent immunostimulatory properties

Journal

EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 40, Issue 1, Pages 134-141

Publisher

WILEY-BLACKWELL
DOI: 10.1002/eji.200939258

Keywords

CD25; CD39; FOXP3; Inducer; Proliferation

Categories

Funding

  1. National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology & Immunology Center [P30 AI027763, AI060379, AI068498, AI066917, AI042590]
  2. AIDS Research Institute (ARI)
  3. National Institutes of Health, University of California, Berkeley, School of Public Health, Division of Epidemiology, Berkeley, California [94720-7360]
  4. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R21AI060379, R01AI068498, R01AI076059, K01AI066917, U01AI042590, R01AI060379] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The complexity of immunoregulation has focused attention on the CD4(+) T suppressor regulatory cell (T-reg), which helps maintain balance between immunity and tolerance. An immunoregulatory T-cell population that upon activation amplifies cellular immune responses was described in murine models more than 30 years ago; however, no study has yet identified a naturally occurring T inducer cell type. Here, we report that the ectoenzyme CD39/NTPDase1 (ecto-nucleoside triphosphate diphosphohydrolase 1) helps to delineate a novel population of human inducer CD4(+) T cells (T-ind) that significantly increases the proliferation and cytokine production of responder T cells in a dose-dependent manner. Furthermore, this unique T-ind subset produces a distinct repertoire of cytokines in comparison to the other CD4(+) T-cell subsets. We propose that this novel CD4(+) T-cell population counterbalances the suppressive activity of suppressor T-reg in peripheral blood and serves as a calibrator of immunoregulation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available